Cargando…

Non-Genomic Biomarkers of Risk in Ovarian Cancer

Detalles Bibliográficos
Autores principales:	Pinheiro, Simone P., Cramer, Daniel W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850568/ https://www.ncbi.nlm.nih.gov/pubmed/18057519 http://dx.doi.org/10.1155/2007/864803

Ejemplares similares

Blood and Urine Markers for Ovarian Cancer: A Comprehensive Review
por: Terry, Kathryn L., et al.
Publicado: (2004)

Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe
por: Morrison, P. J., et al.
Publicado: (1999)

Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
por: Poulin, N., et al.
Publicado: (2003)

Discovery of Ovarian Cancer Biomarkers in Serum Using NanoLC Electrospray Ionization TOF and FT-ICR Mass Spectrometry
por: Bergen, H. Robert, et al.
Publicado: (2004)

Early Detection of Ovarian Cancer
por: Badgwell, Donna, et al.
Publicado: (2007)

Claudin Proteins in Ovarian Cancer
por: Morin, Patrice J.
Publicado: (2007)

Markers of Angiogenesis in Ovarian Cancer
por: Merritt, William M., et al.
Publicado: (2007)

Etiology and Pathogenesis of Epithelial Ovarian Cancer
por: Mok, Samuel C., et al.
Publicado: (2007)

Increased Expression of the Pro-Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer
por: Page, Robert E., et al.
Publicado: (2007)

Biomarkers in Cervical Cancer Screening
por: Wentzensen, Nicolas, et al.
Publicado: (2007)

Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
por: Kerkhof, Marjon, et al.
Publicado: (2007)

Transforming Growth Factor-β and Nitrates in Epithelial Ovarian Cancer
por: Khalifa, Ali, et al.
Publicado: (1999)

Novel Approaches to Identification of Biomarkers for Detection of Early Stage Cancer
por: Kiviat, Nancy B., et al.
Publicado: (2002)

Objective Assessment of Cancer Biomarkers Using Semi-Rare Event Detection
por: van der Laak, Jeroen A. W. M., et al.
Publicado: (2007)

The Promise of Biomarkers in Colorectal Cancer Detection
por: Umar, Asad, et al.
Publicado: (2004)

Immune Prognostic Factors in Ovarian Cancer: Lessons from Translational Research
por: Gimotty, Phyllis A., et al.
Publicado: (2007)

Genetic Counselling and Testing for Hereditary Breast and Ovarian Cancer: The Gent(le) Approach
por: De Vos, M., et al.
Publicado: (1999)

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis
por: Saldova, Radka, et al.
Publicado: (2008)

Polymorphisms of Glutathione S-Transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) Genes and Epithelial Ovarian Cancer Risk
por: Oliveira, Cristiane, et al.
Publicado: (2012)

The association of talc use and ovarian cancer: biased or causal
por: Cramer, Daniel W.
Publicado: (2021)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

Characterization of Plasma Membrane Proteins from Ovarian Cancer Cells Using Mass Spectrometry
por: Springer, David L., et al.
Publicado: (2004)

Expression of Multidrug Resistance-Associated Markers, Their Relation to Quantitative Pathologic Tumour Characteristics and Prognosis in Advanced Ovarian Cancer
por: Brinkhuis, Mariël, et al.
Publicado: (2002)

Shotgun Proteomics and Biomarker Discovery
por: McDonald, W. Hayes, et al.
Publicado: (2002)

Non Classical HLA Genes and Non-HLA Genes in a Population of Infants at Familial Risk of Atopy
por: De Silvestri, A., et al.
Publicado: (2006)

BRCA1 and BRCA2 Germline Mutations Screening in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2010)

A Systems Approach to the Proteomic Identification of Novel Cancer Biomarkers
por: Pitteri, Sharon, et al.
Publicado: (2010)

BRCA1 and BRCA2 Unclassified Variants and Missense Polymorphisms in Algerian Breast/Ovarian Cancer Families
por: Cherbal, Farid, et al.
Publicado: (2012)

Assessment of Cancer-Associated Biomarkers by Positron Emission Tomography: Advances and Challenges
por: Collier, T. Lee, et al.
Publicado: (2002)

Proteomics Approaches to Identify Tumor Antigen Directed Autoantibodies as Cancer Biomarkers
por: Imafuku, Yuji, et al.
Publicado: (2004)

Pharmacogenomic Biomarkers
por: Kirkwood, Sandra C., et al.
Publicado: (2002)

Potential Serological Biomarkers of Cerebral Malaria
por: Lucchi, Naomi W., et al.
Publicado: (2011)

Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers
por: Mar-Aguilar, Fermín, et al.
Publicado: (2013)

TMEM25 Is a Candidate Biomarker Methylated and Down-Regulated in Colorectal Cancer
por: Hrašovec, Sonja, et al.
Publicado: (2013)

Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK
por: Villa-Moruzzi, Emma
Publicado: (2011)

Novel Approaches to Visualization and Data Mining Reveals Diagnostic Information in the Low Amplitude Region of Serum Mass Spectra from Ovarian Cancer Patients
por: Johann, Donald J., et al.
Publicado: (2004)

Ovarian Cancer Biomarker Discovery Based on Genomic Approaches
por: Lee, Jung-Yun, et al.
Publicado: (2013)

The Prognostic Value of Adaptive Nuclear Texture Features from Patient Gray Level Entropy Matrices in Early Stage Ovarian Cancer
por: Nielsen, Birgitte, et al.
Publicado: (2012)

Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
por: Cai, Anping, et al.
Publicado: (2013)

Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI-TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast Cancer
por: Paweletz, Cloud P., et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_nkgf65ba2bt4cauf9vk3q43v9e